Pretreatment of HL60 cells with Deoxyspergualin enhances trail-induced apoptosis independent of caspase 3 activation

Transplantation Proceedings

Volumn 33, Issue 1-2, 2001, Pages 278-

  Wu, J ^a   He, J ^a   Sooudi, S ^a   Jiang, X L ^a   Ray, P ^a   Thomas, F ^a,b   Thomas, J M ^a  

^a University of Alabama at Birmingham   (United States)

^b Boshell Diabetes Research and Education Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXYSPERGUALIN; CASPASE 3;

APOPTOSIS; CELL MATURATION; CELL STRAIN HL 60; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CASPASE 3; CASPASES; ENZYME ACTIVATION; GUANIDINES; HL-60 CELLS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIGANDS; MEMBRANE GLYCOPROTEINS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSPLANTATION TOLERANCE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035080744     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(00)02789-5     Document Type: Conference Paper

References (4)

1. Thomas FT, Tepper MA, Thomas JM, et al: Ann NY Acad Sci 685:175, 1993
2. Thomas JM, Eckhoff DE, Contreras JL, et al: Transplantation 69:2497, 2000
3. Wang J, Zheng L, Lobito A, et al: Cell 98:47, 1999
4. Kaplan MJ, Ray D, Mo RR, et al: TRAIL (Apo2 ligand) and TWEAK (Apo3 ligand) mediate CD4+ T cell killing of antigen-presenting macrophages. J Immunol 164:2897, 2000